Prevalence of Prostatitis-Like Symptoms in a Managed Care Population

Clemens, J. Quentin; Meenan, Richard T.; O’Keeffe‐Rosetti, Maureen; Gao, Sara Y.; Brown, Sheila O.; Calhoun, Elizabeth A.

doi:10.1016/j.juro.2006.03.089

Cited by 46 publications

(35 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Section: Prevalence Of Non-pe Ejd In Patients With Other Medical Condmentioning

confidence: 88%

“…Continent and incontinent men reported 4.7% and 8.5% inability to ejaculate all the time, respectively, compared with 1.1% in the control group [Coyne et al 2011]. In a managed care population, the prevalence of CP/CPPS-like symptoms in men was 5.9% [Clemens et al 2006].The prevalence of CP/CPPS-like symptoms was determined in men concerned about their health.In a large cohort of men participating in a health screening project, the overall prevalence of symptoms suggestive of chronic pelvic pain syndrome was 2.7% with no age dependence [Marszalek et al 2007]. In men during a male-health promotion event, the presence of CP/CPPS-like symptoms was found in 10.5% and painful ejaculation in 5.9% of all respondents [Walz et al 2007b].…”

mentioning

confidence: 93%

See 1 more Smart Citation

A systematic review of the correlates and management of nonpremature ejaculatory dysfunction in heterosexual men

Seyam

2013

Therapeutic Advances in Urology

View full text Add to dashboard Cite

BackgroundThere is an increasing interest in nonpremature ejaculatory dysfunction (non-PE EjD). The frontier of sexual medicine has shifted slowly from erectile dysfunction (ED) to premature ejaculation (PE) and now to non-PE EjD. Two factors have contributed to this shift. First is the search for new areas of research and of novel treatments and second is the better characterization of ejaculatory disorders. The development of questionnaires that better characterize the type of ejaculatory dysfunction (EjD) has helped to identify the problem with more precision in different populations.Interest in the global sexual practice patterns gave insight into the prevalence of non-PE EjD in different areas of the world. Within the non-PE EjD itself, a shift in focus occurred over the years. Early and related to prostatic surgery and retroperitoneal lymph node dissection (RPLND) retrograde ejaculation was reported. With the development of α-blockers and finasteride, retrograde ejaculation, EjD and/or orgasmic dysfunction were reported as A systematic review of the correlates and management of nonpremature ejaculatory dysfunction in heterosexual men Raouf SeyamAbstract Introduction: A better understanding of ejaculatory disorders has led to an increasing interest in nonpremature ejaculatory dysfunction (non-PE EjD). Current reviews on the subject use a symptom-based classification to describe ejaculatory dysfunction even when it is a single case report. While these reviews provide important information on the disorder, a clearer picture of the prevalence of non-PE EjD in relation to the community and various pathophysiologic states is needed. Objectives: The objective of this study was to provide a systematic review of studies of non-PE EjD excluding single case reports. Methods: A systematic review of Medline for terms including ejaculation, orgasm or hematospermia. Association with terms delay, pain or headache was made. The search was restricted to male gender and articles written in English. Abstracts were reviewed and those mainly concerned with premature ejaculation were excluded. Results: A total of 333 articles on non-PE EjD were identified. The condition was reported in community-based studies. In certain patient populations, non-PE EjD was commonly reported in association with antidepressant and antipsychotic treatments, in patients with chronic prostatitis/chronic pelvic pain syndrome, patients with lower urinary tract symptoms particularly in association with medical or surgical treatment, patients with retroperitoneal surgery and in patients with neurological diseases. Few articles were concerned with treatment options. Conclusion: There is a significant prevalence of non-PE EjD in the community and in association with particular disease states or as a side effect of medical or surgical interventions. There is a need to direct efforts to prevent and treat these conditions. Keywords: anhedonia, aspermia, ejaculation, epidemiology, headache, hemospermia, orgasm, pain, prevalence adverse events. It became clear ...

show abstract

Section: Prevalence Of Non-pe Ejd In Patients With Other Medical Condmentioning

confidence: 88%

mentioning

confidence: 93%

A systematic review of the correlates and management of nonpremature ejaculatory dysfunction in heterosexual men

Seyam

2013

Therapeutic Advances in Urology

View full text Add to dashboard Cite

show abstract

“…Dysuria is a clinical problem associated with benign prostatic enlargement (BPH) and/or prostatitis (5). It is a commonly reported toxicity following pelvic radiation therapy and may be difficult to manage (6).…”

Section: Sbrt-related Dysuriamentioning

confidence: 99%

Dysuria Following Stereotactic Body Radiation Therapy for Prostate Cancer

Janowski

Chen

Kim

et al. 2014

International Journal of Radiation Oncology*Biology*Physics

View full text Add to dashboard Cite

“…11 Another study in the Pacific Northwest concluded that the prevalence of IC symptoms was between 6.2% and 11.2% in women, and 2.3% and 4.6% in men. 12 …”

Section: Prevalencementioning

confidence: 99%